gts-21

Small moleculeexperimental

Chemistry & pharmacology

Loading structure…

SMILES

COc1ccc(/C=C2\CCCN=C2c2cccnc2)c(OC)c1
Mol. weight
308.38 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 3-(2,4-dimethoxybenzylidene)anabaseine
  • 3-(2,4-dimethoxybenzylidene)anabaseine
  • 3-(2,4-dimethoxybenzylidene)anabaseine
  • dimethoxybenzylidene anabaseine
  • dimethoxybenzylidene anabaseine
  • dimethoxybenzylidene anabaseine
  • dmxba
  • dmxb-a
  • dmxb-a
  • dmxb-a
  • dmxb-anabaseine
  • dmxb-anabaseine
  • gts 21
  • gts-21
  • gts-21
  • gts-21
  • gts-21

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02432066Phase 2Jun 29, 2017University of Florida
NCT02458313Phase 1Nov 1, 2015University of Colorado, Denver
NCT02538081Phase 1/Phase 2 (Phase 2)Aug 1, 2015Department of Veteran Affairs, University of Colorado, Denver
NCT02111551Phase 1Jun 1, 2015University of Colorado, Denver
NCT01400477Phase 2Jul 1, 2011National Institute of Mental Health (NIMH), University of Colorado, Denver
NCT00783068N/AAug 1, 2008CoMentis, Radboud University
NCT00419445Phase 1/Phase 2 (Phase 2)Feb 1, 2007CoMentis
NCT00414622Phase 2Nov 1, 2006CoMentis
NCT00255918Phase 1Mar 1, 2004National Institute of Mental Health (NIMH), University of Colorado, Denver
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of Colorado, DenverAcademic/Hospital5422004
CoMentisFor profit3222006
National Institute of Mental Health (NIMH)Government2022004
Department of Veteran AffairsGovernment1112015
Radboud UniversityAcademic/Hospital1112008
University of FloridaAcademic/Hospital1112017
6 organizations
Page 1 / 1